Reply to ‘Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab’ – (Eye 29, 1239 (September 2015))

10 September 2015

This news item is available to RCOphth members only, please log in below to access.